![]() |
|
Contact Information
Callisto Pharmaceuticals Inc (AMEX: KAL)
See Map: Google Maps - Yahoo! Maps - MapQuest Business Description
Their primary focus is the clinical development of two drugs to treat cancer, Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma (MM) and bone resorption.
|
See Also
Sponsored Links
|
| More businesses in this category: | ||
|
Biotech Holding Ltd - Previous |
| |
|